CBEJ2J.jpg
 BULK BILLED

Epilepsy diagnosis and management made easy

 

 Taking healthcare from the hospital to the home

Seer offers a long-term ambulatory video-EEG-ECG monitoring for epilepsy diagnostics and a web platform for data management.

Gold standard epilepsy diagnostics in the comfort of the home.
Fully reimbursed by Medicare.
No barriers to great healthcare.
 
Patients and Caregivers
If you, or a loved one, is experiencing seizures, fainting spells or blackouts, we can help you get a diagnosis faster, so you take back control of your life.
 
 

Convenience and comfort

Seer can monitor you at home with minimal impact on your life, so you don't have to spend days in a hospital.

No waitlist

With Seer, you do not have to wait for scarce hospital resources. No waitlists mean you get an answer quickly.

Refining medications

We provide an opportunity to refine medications using a quantative assessment of your brain and heart signals.

 
 
Medical Professionals
We are the largest ambulatory EEG diagnostic service in Australia, with over 100 referring neurologists. Your patients are in safe hands.
 
 

Video-EEG-ECG

Our at-home video-EEG-ECG service bundles multiple tests, so we see the full picture of our patients neural and cardiac health.

In the cloud

Online referrals and data management mean you can spend less time on admin, and more time on the things that matter.

 
Seer Cloud
The Seer Cloud is a web-based platform that enables seamless management, review and global collaboration on epilepsy-related data. Data types include diaries, clinical records, medical imaging (MRI, PET, SPECT, CT), time series data (EEG and other wearables) and video.
 
Seer System
Before Seer, gold standard diagnostic testing required a one-week stay in hospital. The Seer System enables acquisition of gold standard diagnostic information in the comfort and convenience of the home.
 
Trials
Our long-term at-home video-EEG-ECG monitoring service, coupled with the power of the Seer Cloud and Beagle - our event-logging app - provides the new gold standard for trialling therapeutics or new devices. Get in touch for more information.